Biolase ROE 2010-2023 | BIOL
Current and historical return on equity (ROE) values for Biolase (BIOL) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Biolase ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2023-12-31 |
$-0.04B |
$0.00B |
-660.87% |
| 2023-09-30 |
$-0.03B |
$0.01B |
-400.00% |
| 2023-06-30 |
$-0.03B |
$0.01B |
-341.18% |
| 2023-03-31 |
$-0.03B |
$0.01B |
-244.90% |
| 2022-12-31 |
$-0.03B |
$0.01B |
-187.10% |
| 2022-09-30 |
$-0.02B |
$0.01B |
-117.07% |
| 2022-06-30 |
$-0.02B |
$0.02B |
-77.55% |
| 2022-03-31 |
$-0.01B |
$0.02B |
-51.38% |
| 2021-12-31 |
$-0.02B |
$0.03B |
-52.46% |
| 2021-09-30 |
$-0.02B |
$0.03B |
-63.55% |
| 2021-06-30 |
$-0.03B |
$0.03B |
-136.26% |
| 2021-03-31 |
$-0.04B |
$0.03B |
-237.29% |
| 2020-12-31 |
$-0.03B |
$0.01B |
-566.67% |
| 2020-09-30 |
$-0.03B |
$0.01B |
-711.11% |
| 2020-06-30 |
$-0.02B |
$0.00B |
-2666.67% |
| 2020-03-31 |
$-0.02B |
$-0.00B |
-1266.67% |
| 2019-12-31 |
$-0.02B |
$0.00B |
-514.29% |
| 2019-09-30 |
$-0.02B |
$-0.00B |
-400.00% |
| 2019-06-30 |
$-0.02B |
$0.00B |
-221.05% |
| 2019-03-31 |
$-0.02B |
$0.01B |
-162.96% |
| 2018-12-31 |
$-0.02B |
$0.01B |
-122.22% |
| 2018-09-30 |
$-0.02B |
$0.02B |
-102.22% |
| 2018-06-30 |
$-0.02B |
$0.02B |
-96.84% |
| 2018-03-31 |
$-0.02B |
$0.03B |
-88.00% |
| 2017-12-31 |
$-0.02B |
$0.03B |
-90.32% |
| 2017-09-30 |
$-0.02B |
$0.02B |
-93.02% |
| 2017-06-30 |
$-0.02B |
$0.03B |
-79.12% |
| 2017-03-31 |
$-0.02B |
$0.02B |
-84.71% |
| 2016-12-31 |
$-0.02B |
$0.02B |
-80.90% |
| 2016-09-30 |
$-0.01B |
$0.03B |
-56.52% |
| 2016-06-30 |
$-0.02B |
$0.02B |
-65.22% |
| 2016-03-31 |
$-0.02B |
$0.02B |
-69.23% |
| 2015-12-31 |
$-0.02B |
$0.03B |
-63.87% |
| 2015-09-30 |
$-0.02B |
$0.03B |
-61.76% |
| 2015-06-30 |
$-0.02B |
$0.03B |
-62.81% |
| 2015-03-31 |
$-0.02B |
$0.04B |
-77.42% |
| 2014-12-31 |
$-0.02B |
$0.04B |
-110.77% |
| 2014-09-30 |
$-0.02B |
$0.01B |
-206.45% |
| 2014-06-30 |
$-0.02B |
$0.00B |
-226.67% |
| 2014-03-31 |
$-0.01B |
$0.01B |
-160.00% |
| 2013-12-31 |
$-0.01B |
$0.01B |
-133.33% |
| 2013-09-30 |
$-0.01B |
$0.01B |
-90.00% |
| 2013-06-30 |
$-0.01B |
$0.01B |
-60.00% |
| 2013-03-31 |
$-0.01B |
$0.01B |
-46.51% |
| 2012-12-31 |
$-0.00B |
$0.01B |
-35.56% |
| 2012-09-30 |
$-0.01B |
$0.01B |
-60.87% |
| 2012-06-30 |
$-0.01B |
$0.01B |
-56.00% |
| 2012-03-31 |
$-0.01B |
$0.01B |
-44.44% |
| 2011-12-31 |
$-0.01B |
$0.01B |
-43.48% |
| 2011-09-30 |
$-0.00B |
$0.01B |
-40.00% |
| 2011-06-30 |
$-0.01B |
$0.02B |
-166.67% |
| 2011-03-31 |
$-0.01B |
$0.00B |
800.00% |
| 2010-12-31 |
$-0.01B |
$-0.00B |
960.00% |
| 2010-09-30 |
$-0.01B |
$-0.00B |
-866.67% |
| 2010-06-30 |
$-0.01B |
$-0.00B |
-189.47% |
| 2010-03-31 |
$-0.00B |
$0.00B |
-42.86% |
| 2009-12-31 |
$-0.00B |
$0.01B |
-40.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.005B |
$0.049B |
|
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
|
